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PathogenesisExperimental mouse models were used to compare virulence and reproduction rate of three mouse-adapted
variants of the PR8 inﬂuenza A virus strain. We observed large differences in pathogenicity in two mouse
strains. The PR8M variant was lethal in DBA/2J mice but not in C57BL/6J mice, whereas PR8F and hvPR8
variants were lethal in both mouse strains. High lethality of PR8M in DBA/2J correlated with high viral load at
early time points after infection and spread of the virus into alveolar regions. Also, higher viral loads and
mortality in mice infected with PR8F resulted in a higher number of inﬁltrating leukocytes. 3D-protein
structure predictions of the HA indicated amino acid sequence alterations which may render the HA cleavage
site in PR8F more accessible to host proteases. Infection of C57BL/6J mice with a re-assorted PR8 virus
revealed that the HA gene is the main determinant of virulence of the PR8F variant.nschweig, Germany. Fax: +49
K. Schughart).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The course and outcome of an inﬂuenza virus A infection is
inﬂuenced by several viral and host factors. Virulence factors of the
virus determine its host speciﬁcity but also the severity of disease
(Ducatez et al., 2008; Jang et al., 2009; Krug, 2006; Rolling et al., 2009;
Salomon and Webster, 2009; Scheiblauer et al., 1995; Song et al.,
2009; Yen et al., 2009). Reports on host factors regulating viral
propagation are manifold and include importins (Gabriel et al., 2008),
kinases (Pleschka et al., 2001), caspases (e.g. (Wurzer et al., 2003) or
effectors of the type I interferon response (Haller et al., 2009).
Furthermore, other risk factors of the host like obesity or pregnancy
became evident during the recent swine ﬂu pandemics (Scriven et al.,
2009; Yates et al., 2010). Furthermore, genetic factors in humans
associated with a higher susceptibility to inﬂuenza infections and
severe disease outcome have been suspected for the 1918 pandemics
as well as the H5N1 human infections (Albright et al., 2008;
Gottfredsson et al., 2008; Horby et al., 2010).The main antigenic determinants of inﬂuenza A viruses are the
haemagglutinin (HA) and the neuraminidase (NA) genes. Based on
the antigenicity of these membrane-associated glycoproteins, sixteen
HA (H1–H16) and nine NA (N1–N9) subtypes (Bouvier and Palese,
2008) have been described until now. Inﬂuenza A virus enters the
host cells through binding of the HA protein to the N-acetylneur-
aminic (sialic) acids (alpha 2,3 or alpha 2,6) present on the cell
surface. The binding to sialic acids occurs via the interaction of a
depression at the distal surface of the globular head of the HA
molecule (Weis et al., 1988). The inﬂuenza HA protein (HA0) is
synthesized as an immature protein and is cleaved by host proteases
into the two subunits HA1 and HA2. Cleavage is required for
infectivity and is an important determinant for pathogenicity in
human and avian hosts. The HA1 subunit represents the receptor
binding domain, whereas the HA2 subunit contains the fusion
peptide. Furthermore, inﬂuenza virus can adapt to new host species
through the modiﬁcation of the HA protein sequence, especially at the
cleavage site (Couceiro et al., 1993; Matrosovich et al., 2004). In
experimental systems, adaptation can be achieved via several
passages in a new host which results in variations of the receptor-
binding site in the HA (Grimm et al., 2007) as well as modiﬁcations of
NA and polymerase genes. However, there are also examples of H5
and H7 virus subtypes isolated from birds (Belser et al., 2007; Gao
Fig. 1. PR8M reproduced to high levels in the lungs of DBA/2J mice but not in C57BL/6J
mice at early time points after infection. Nine DBA/2J and C57BL/6J mice were infected
intra-nasally with a dose of 2×103 FFU of PR8M virus and viral load in the lungs was
measured at 12 h p.i. by focus formation assay. At this time point, the amounts of
infectious particles in C57BL/6J mice were below the level of detection. For DBA/2J mice
the mean values±SEM are shown.
Fig. 2. The number of infected cells and spreading of PR8M virus into alveolar regions
was higher in DBA/2J compared to C57BL/6J mice. Three DBA/2J and three C57BL/6J
mice were infected intra-nasally with 2×103 FFU of PR8M viruses. Three lung sections
from each mouse (total of nine sections per mouse strain) were stained with anti-
inﬂuenza NP antibody and haematoxylin. The numbers of infected cells in bronchiolar
(A) and in alveolar (B) regions were calculated per 625 μm2 total surface of lung tissues
after 12, 24 and 48 h p.i. Mean values±SEM are shown. DBA/2J and C57BL/6J mice were
compared for statistical signiﬁcant differences using non-parametric Mann–Whitney-
U-test. **: p valueb0.01; ***: p valueb0.001.
37P. Blazejewska et al. / Virology 412 (2011) 36–45et al., 1999) as well as the vH1N1/2009 which can replicate in mice
without prior adaptation (Belser et al., 2010).
In this study, we used three different mouse-adapted variants of
the inﬂuenza virus strain A/Puerto Rico/8/34. The PR8M and PR8F
variants are closely related in sequence to the PR8 Mount Sinai strain
(Schickli et al., 2001). These two variants were derived from the same
ancestor but did acquire some additional changeswhen propagated in
different laboratories (PR8M in Muenster and PR8F variant in
Freiburg, see Materials and methods for details). The hvPR8 is a
variant of the PR8 Cambridge strain and is more distantly related to
the other two variants. It exhibits an extremely high replication rate in
mice which is a decisive factor in the lethal outcome of infection
(Grimm et al., 2007).
In mouse model systems, genetic factors, such as gene mutations
(e.g. Mx1, Stat1, Pkr, Infar1, Ncr1 — (Bergmann et al., 2000; Gazit et al.,
2006; Haller et al., 1976; Koerner et al., 2007; Tumpey et al., 2007) as
well as differences in the genetic background (Boon et al., 2009, 2010;
Dinget al., 2008; Srivastava et al., 2009) have been clearly demonstrated
to play an important role in host susceptibility or resistance to infection.
Using the mouse-adapted PR8M (H1N1) variant and the strain A/Seal/
Massachusetts/1/80 (H7N7; SC35M)we previously showed thatDBA/2J
mice are highly susceptible to both virus subtypes whereas C57BL/6J
mice are resistant (Srivastava et al., 2009).
Here, we demonstrate that there are large differences in
pathogenicity of the three mouse-adapted PR8 inﬂuenza A variants
in two inbred mouse strains. While the PR8M variant is only lethal for
DBA/2J mice, the PR8F and the hvPR8 variants were lethal for both,
DBA/2J and C57BL/6J mouse strains. The high lethality of PR8F and
hvPR8 correlated with high viral load. Also, PR8F infected C57BL/6J
mice showed a higher number of inﬁltrating leukocytes in infected
lungs compared to PR8M infected mice. Sequence comparisons and
subsequent 3D-predictions of the HA variants from PR8M and PR8F
indicated differences in the folding of the HA which may inﬂuence its
interaction with cellular proteases and thus might contribute to the
higher virulence of the PR8F variant. Infection of C57BL/6J mice with a
re-assorted virus carrying the HA segment of PR8F in the genetic
background of PR8M showed that indeed the HA gene is the major
determinant for lethality.
Results
Higher propagation rates and enhanced spread into alveolar regions in
the lungs of DBA/2J mice after infection with PR8M virus
We previously showed that DBA/2J mice were much more
susceptible to the PR8M inﬂuenza virus variant than C57BL/6J mice
(Srivastava et al., 2009). The extremely high susceptibility of DBA/2J
mice was associatedwith a higher replication rate in the lungs of DBA/
2J compared to C57BL/6J mice (Srivastava et al., 2009). We now
expanded these studies by analyzing earlier time points after infection
and performing semi-quantitative analysis of infected cells in
histological sections. All infections were performed at an infection
dose of 2×103 FFU. At this dose, different mouse strains exhibited
differential responses to the low pathogenic variant PR8M (Srivastava
et al., 2009) and it was thus considered to represent an appropriate
dose to determine differences in pathogenicity of different virus
variants.
At 12 h post infection (p.i.), PR8M titers in the lungs of infected
DBA/2J mice reached 1×104 FFU whereas virus titers in infected
C57BL/6J mice were below the detection limit (Fig. 1). These
observations suggest a cell intrinsic difference in the binding or
replication capacity of respiratory epithelial cells in DBA/2J mice
compared to C57BL/6J. The higher viral loads in DBA/2J mice at early
time points p.i. could either be due to a higher replication rate of the
virus in infected cells or may be the result of a higher number of cells
infected. To address this question, we examined parafﬁn sections fromPR8M infected lungs of DBA/2J and C57BL/6J mice and counted the
number of infected cells in the bronchiolar and alveolar regions after
immune-histochemical staining of the viral nucleoprotein (NP). In the
lungs of DBA/2J mice, virus-infected cells were present both in the
38 P. Blazejewska et al. / Virology 412 (2011) 36–45bronchiolar and alveolar regions already at 12 h p.i., whereas in
C57BL/6J mice no infected cells were detected at this time point
(Fig. 2). At later times p.i. signiﬁcantly higher numbers of infected
cells were observed in DBA/2J mice compared to C57BL/6J mice in
both bronchiolar (Fig. 2A) and alveolar regions (Fig. 2B). Most
remarkably, the virus did spread into alveolar regions much earlier
and to a signiﬁcantly higher level in DBA/2J compared to C57BL/6JFig. 3. Histological sections of lungs from DBA/2J and C57BL/6J mice infected with PR8M viru
DBA/2J mice. DBA/2J (A–F) and C57BL/6J (G–L) mice were infected intra-nasally with 2×10
and haematoxylin. Already at day 1 p.i., large patches of virus-infected cells (brown staining)
bronchiolar regions (not shown). At day 2 p.i., PR8M infected cells could be detected through
regions (solid arrows, D–F). In C57BL/6J lungs, the spread of PR8M virus (cells stained brow
arrows). Scale bars represent 200 μm.mice (Fig. 2B). Fig. 3 shows examples of histological pictures
illustrating the rapid spread of PR8M virus into the alveolar regions
of DBA/2J mice. In conclusion, these observations not only demon-
strated that a higher number of cells was infected in DBA/2J compared
to C57BL/6J mice but also that the virus did spread more deeply into
the alveolar regions of the lungs in DBA/2J mice. This enhanced spread
is most likely the reason for the high mortality rate in DBA/2J mice.s. PR8M infected cells were observed in bronchiolar and alveolar regions in the lungs of
3 FFU of PR8M virus. Serial lung sections were stained with anti-inﬂuenza NP antibody
were found in DBA/2J mice in alveolar regions (solid arrows, A–C) in addition to infected
out the lungs in DBA/2J mice, both in bronchiolar (dashed arrows, D–E) and in alveolar
n) at day 1 (G–I) and day 2 (J–L) p.i. was mostly limited to bronchiolar regions (dashed
Fig. 4. Difference in the susceptibility of DBA/2J and C57BL/6J mice to infections with PR8M, PR8F and hvPR8 virus variants. DBA/2J and C57BL/6J mice were infected intra-nasally
with 2×103 FFU PR8M (A), PR8F (B) or hvPR8 (C) and weight loss was monitored over a 14-day period. For comparison, also previously published data (modiﬁed from (Srivastava
et al., 2009) for weight loss and survival of DBA/2J and C57BL/6J mice infected with the PR8M variant was included (A, D, E). Mean percent of body weight change (±SEM) is shown,
and n refers to the total number of mice from two independent experiments infected in each group. Survival of DBA/2J mice is shown in (D) and of C57BL/6J mice in (E). Mortality
also included mice that were sacriﬁced because they had lost more than 25% of body weight.
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and C57BL/6J mice and replicate to comparable levels
Next, we infected DBA/2J and C57BL/6J mice with two additional
PR8 variants, PR8F and hvPR8 which were described to be also lethal
for C57BL/6J mice (Grimm et al., 2007). As shown in Figs. 4A and B, the
kinetics of weight loss and survival of DBA/2J and C57BL/6J infected
with PR8F and hvPR8 were largely similar (Figs. 4B, C) which is in
contrast to the results observed for PR8M where DBA/2J mice were
much more susceptible (Fig. 4A). In DBA/2J mice, viral loads were
similar after infection with PR8M (Fig. 5A) and PR8F (Fig. 5B) and
even higher after infection with hvPR8 (Fig. 5C). In C57BL/6J mice,
viral load was lower than in DBA/2J mice after infections with PR8M
virus (Fig. 5A). However, viral loads were similarly high in C57BL/6J
and DBA/2J mice after infection with PR8F or hvPR8 virus (Figs. 5B, C).Thus, the differences in viral loads correlated well with the severity of
weight loss and mortality for all three virus variants in the twomouse
strains studied. These data suggest that a continuously high viral load
(above 105 FFU) will lead to severe tissue damage, lung dysfunctions
and subsequent death.
In histological sections of mice infected with PR8F and hvPR8,
many virus infected cells could be detected in alveolar regions, both in
C57BL/6J and in DBA/2J mice at days 1 and 2 after infection (Fig. 6).
This is in contrast to PR8M infections where NP-positive cells were
mostly restricted to bronchiolar regions in C57BL/6J mice (Figs. 3G–L).
These observations demonstrated again that the virulence of the
different PR8 variants correlated well with the capability of the virus
to replicate in alveolar regions, suggesting that penetration of
inﬂuenza virus into these deeper regions of the lung is a major
determinant of a lethal pathology.
Fig. 5. PR8F and hvPR8 reproduced to similar levels in the lungs of DBA/2J and C57BL/6J mice. DBA/2J and C57BL/6J were infected intra-nasally with 2×103 FFU of PR8M (A), PR8F
(B) or hvPR8 (C) and viral load in the lungs was measured at indicated times p.i. using focus formation assay. For comparison, also previously published data (modiﬁed from
Srivastava et al., 2009) on the viral load in the lungs of DBA/2J and C57BL/6J after infectionwith the PR8M variant was included (A). Six DBA/2J and six C57BL/6J mice were used for all
time points. Mean values±SEM from a total of two independent experiments are shown. DBA/2J and C57BL/6J mice were compared for statistical signiﬁcant differences using non-
parametric Mann–Whitney-U-test. ***: p valueb0.001.
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inﬁltration
Besides the viral load, also the strength of the inﬂammatory immune
response is thought to contribute to the severity of disease. In particular,
deleterious inﬂammatory responses have been suggested in the context
of lethal H5N1 infections in humans and animals. Therefore, we
investigated the degree of immune cell inﬁltration in C57BL/6J mice
infected with PR8M and PR8F, since viral loads in C57BL/6J mice were
different after infection with these two variants. As shown in Fig. 7, at
day 1 p.i. similarly lownumbers of inﬁltrating leukocyteswere observed
after infectionwithboth viruses and in non-infected controls. At day 2p.
i., a slightly higher number of inﬁltrates was observed in PR8F infected
mice, but at day 3 p.i. a signiﬁcantly higher number of inﬁltrating cells
was observed in PR8F compared to PR8M infected mice (Fig. 7). Thus, a
higher inﬂammatory responsewas correlatedwith high viral load and a
more severe lung pathology. It should, however, be noted that such a
strong link between viral load and inﬂammatory response may not
always be observed. In particular, such a correlation may not be
apparent when more distantly related virus subtypes are compared or
when mice are infected that are genetically different by mutation or
have been treated with anti-inﬂammatory drugs.
Differences in the HA amino acid sequence may account for different
protein folding and protease cleavage in the PR8F versus PR8M variant
The PR8M and PR8F were obtained from two different laboratories
and were not previously compared directly. Here, we observed a
signiﬁcantly different pathogenicity of PR8M and PR8F in C57BL/6J
mice. To obtain further insights into the molecular basis of thesedifferences, we sequenced all viral segments from both viruses.
Several differences in the predicted amino acid sequences were
observed in various viral segments.
Thepredicted aminoacid sequence of theHAgeneexhibited six amino
acid changesbetweenPR8FandPR8M(S10C, S123R,G276D,M288I, T337I
and I349F, respectively). The most frequently observed amino acids at
these positions are (data from Inﬂuenza Research Database (IRD, http://
www.ﬂudb.org/brc/home.do?decorator=inﬂuenza)): 10 C, S123, G276,
M288, 337I, I349. Thus, the positions 123, 276, 288 and 349 in PR8Mdiffer
from this consensus andmost likely account for thedifference in virulence
between PR8F and PR8M. Most of the changes resided in the HA1 region,
only I349F was at the beginning of HA2 just after the cleavage site. T337I
and I349F surrounded the cleavage site. There were no changes observed
in the predicted fusion peptide itself and no amino acid differences were
found which would predict a difference in glycosylation. Modeling of the
potential inﬂuence of the variation in amino acids at positions T337I and
I349F suggested a difference in HA folding (Fig. 8) in a loop formed by
amino acids 335 to 351. This structural change may enable the cleavage
peptide in the PR8F HA to bemore exposed and thus to ﬁt better into the
active site of trypsin-like proteases. Therefore, these alterations in PR8F
may allow for better processing of the HA by host proteases and thereby
render this variant more infectious.
In the predicted NA protein sequence, two amino acid differences
were observed between PR8F and PR8M, at positions 8 and 131. The
predicted PA sequences showed two difference at positions 11 and 15,
the predicted NP sequence revealed three amino acid differences at
positions 7, 12 and 496, the predicted PB1 sequences showed four
differences at positions 2, 7, 10 and 436, and the predicted PB2
sequence showed one amino acid difference at position 4. No
differences were observed in the NS and M gene segments. For all
Fig. 6. Histological sections of lungs from C57BL/6J mice infected with PR8F and hvPR8 virus variants. Three C57BL/6J mice (per virus variant) were infected intra-nasally either with
2×103 FFU of PR8F (A,B,E,F) or hvPR8 (C,D,G,H). Serial lung sections were stained with anti-inﬂuenza NP antibody and haematoxylin. At day 1 p.i., large areas of virus-infected cells
(brown staining) were found in alveolar regions (solid arrows in A, B) in addition to infected bronchiolar regions (dashed arrow, A) of C57BL/6J mice infected with PR8F. Similarly, at
day 1 p.i., C57BL/6J mice infected with hvPR8 presented NP-positive cells in alveolar (solid arrows, C,D) and bronchiolar regions (dashed arrow, C) with slightly more alveolar regions
infected compared to PR8M infected mice. At day 2 p.i., PR8F (E,F) and hvPR8 (G,H) infected cells could be detected throughout the lungs of C57BL/6J mice, both in bronchiolar
(dashed arrows, PR8F-E, hvPR8-G) and in alveolar regions (solid arrows, PR8F in E,F and hvPR8 in G,H). Scale bars represent 200 μm.
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which was most common to all sequenced H1N1 viruses in the IRD.
The HA segment is the main determinant for the high virulence of the
PR8F virus variant
To determine whether the HA segment indeed accounts for the
difference in virulence between the PR8M and PR8F variants, we
generated a genetic re-assortant (PR8M-HA-F) which contained theHA fragment of the PR8F variant in the background of the PR8M virus.
As shown in Fig. 9, survival wasmuch lower and signiﬁcantly different
(pb0.01, log rank test) for PR8M-HA-F compared to PRM infected
C57BL/6J mice. Only 20% of PR8M-HA-F infected mice survived
whereas all mice survived an infection with PR8M virus. On the
other hand, survival was slightly but signiﬁcantly (pb0.01, log rank
test) higher for PR8M-HA-F compared to PR8F infected mice. These
results demonstrated that the HA segment is indeed the main
determinant of the high virulence of the PR8F variant.
Fig. 7. Lung inﬁltrates correlatewith viral load and severity of disease. Inﬁltrating immune
cells were isolated from mouse lung homogenates and analyzed by FACS by staining for
CD45expression. The numberof inﬁltrating CD45-positive cellswas determined for days 1
to 3 after infection with either PR8M or PR8F virus. Non-infected mice were used as
control. The number of inﬁltrates at days 2 and 3 p.i. were signiﬁcantly higher in infected
compared to control (uninfected) mice (pb0.01 for both days, using non-parametric
Kruskall–Wallis test). Inﬁltrates in both PR8M and PR8F infected mice changed
signiﬁcantly over time (pb0.05 and pb0.01 respectively using non-parametric Kruskall–
Wallis test). The amount of inﬁltrates at day 3 p.i. was signiﬁcantly higher (pb0.01 using
Mann–Whitney-U-test) in mice infected with PR8F than in mice infected with PR8M (B).
Mean values±SEM are shown of n=5mice for control and days 1 or 2 and n=4mice for
day 3. One of two experiments with similar results is shown.
Fig. 9. The re-assorted virus PR8M-HA-F virus is highly lethal for C57BL/6J mice. Ten
C57BL/6J mice (for each virus variant) were infected intra-nasally with each 2×103 FFU
PR8M, PR8M-HA-F or PR8F and survival was monitored over a 14-day period. Infection
with PR8M-HA-F virus resulted in high mortality which was signiﬁcantly different to
the survival rate of PR8M infected mice (pb0.01 using log rank test). Mortality also
includedmice that were sacriﬁced because they had lost more than 25% of body weight.
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The outcome of an infection is the result a complex interplay
between the virulence of the pathogen and the host response. Both
are inﬂuenced by environmental but also to a large extent by geneticFig. 8. Two-amino acid changes near the HA cleavage side predict better exposure of the prote
from PR8M and PR8F were modeled and compared. The surface model of the region between
surface of the rest of the protein (A, red) and may therefore be less available to ﬁt into the po
was predicted to be better exposed and may thus exhibit a better interaction with host prot
cleavage site peptide of PR8M is shown in blue, the cleavage site peptide in PR8F in red. Thfactors. Here, we studied the host–pathogen-interactions for three
different variants of a mouse-adapted inﬂuenza virus, PR8: a low
pathogenic variant PR8M, a highly pathogenic variant PR8F which is
lethal to mice at intermediate doses of infection, and a very highly
pathogenic variant hvPR8 which is lethal even at low doses of
infection (Grimm et al., 2007; Srivastava et al., 2009). The host
response was investigated in two different mouse strains: the DBA/2J
mouse strain being highly susceptible to all three virus variants and
the C57BL/6J mouse strain showing differential susceptibility depend-
ing on the virus variant.
DBA/2J mice were susceptible to all three PR8 virus variants
exhibiting dramatic weight loss after infection with 2×103 FFU, andase cleavage site of the HA in PR8F. The three-dimensional structures of the HA proteins
residues 337 and 349 in the loop of the PR8M variant was predicted to be closer to the
cket of the host proteases. The surface model of this region in the PR8F variant (B, blue)
eases. The protease cleavage site is shown in yellow in the ribbon model in (C). The HA
e amino acid T337I is marked in cyan and I349F in violet (solid arrows, C).
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mice. C57BL/6J mice showed a differential response. While they
survived infections with the low pathogenic PR8M, they succumbed
to both the PR8F and hvPR8 variant. Analysis of virus propagation in
the lung showed that the lethal outcome strongly correlated with a
high viral load. DBA/2J mice exhibited a much higher viral load
compared to C57BL/6J mice when infected with the low virulent
PR8M variant. In contrast viral loads after infection with the PR8F
variant were similarly high in C57BL/6J and DBA/2J infected mice. For
the very high virulent virus hvPR8 it has been previously shown that it
replicates to a much higher rate compared to other inﬂuenza virus
isolates (Grimm et al., 2007). Consistent with these ﬁndings we also
observed the highest replication rates in hvPR8 infected mice, with
DBA/2J and C57BL/6J exhibiting similar levels of virus in their lungs.
DBA/2J mice were also shown to exhibit a higher susceptibility
compared to C57BL/6J mice when infected with other inﬂuenza A
virus subtypes (Boon et al., 2010; Srivastava et al., 2009).
Taken together, our results suggest that there might be a tolerable
threshold of virus propagation in the lungs of infected animals below
which viral reproduction is not lethal whereas above this threshold
enhanced damage in respiratory epithelia occurs. The high viral
reproduction thus leads to irreversible pathologies of the lung and a
fatal outcome, especially if the virus is spreading into the alveolar
regions. In our experiments this threshold appeared to be between
105 and 106 viruses per lung for infections with mouse-adapted PR8
virus. The importance of a threshold in virus titers was shown to play
a role in infections with H5N1 inﬂuenza virus (Hatta et al., 2010) and
also in the outcome of Simian Immunodeﬁciency Virus and Simian–
Human Immunodeﬁciency Viruses (Ten Haaft et al., 1998) as well as
Lassa Virus (Baize et al., 2009) in monkeys.
It should also be noted, that several studies have shown that the
host immune response is an important factor in the severity of
inﬂuenza-induced pathology. Infection-associated hyper-inﬂamma-
tory responses may contribute to tissue damage and pathogenicity
with lethal outcomes (Aldridge et al., 2009; de Jong et al., 2006;
Herold et al., 2008; Kash et al., 2006; La Gruta et al., 2007; Perrone
et al., 2008; Tumpey et al., 2005). Inhibition of strong inﬂammatory
responses, e.g. by anti-inﬂammatory drugs was shown to result in
improved survival even when viral loads were unaltered (Aldridge
et al., 2009; Budd et al., 2007; Palamara et al., 2005; Zheng et al.,
2008). Here, we observed higher leukocyte inﬁltrates after infection
with the highly virulent PR8M compared to the less virulent PR8M
virus variant in C57BL/6J mice. These results demonstrate that there is
a stronger inﬂammatory response during lethal infections.
After administration of low virulent PR8M virus in DBA/2J mice,
the viral loads were already very high at 12 h p.i. and more cells were
infected in DBA/2J lungs, compared to PR8M infections in C57BL/6J
mice. However, at later time points, the slope of increase in viral loads
was similar for both mouse strains. This high permissiveness of virus
reproduction for the low virulent PR8M virus in DBA/2J mice,
especially at early time point p.i. could be explained in several ways.
First, DBA/2J mice may exhibit a higher number of receptors allowing
more cells to be infected. Second, the uptake of virus and transport to
the nucleus is more efﬁcient in DBA/2J mice. Third, assembly or
release of the virus from infected cells is more efﬁcient in DBA/2Jmice.
Forth, the innate immune response is less efﬁcient in DBA/2J mice. We
are currently addressing these hypotheses in more detail in lung
organ cultures.
DBA/2J mice do not show any overt signs of a general deﬁciency in
the early innate immune response because no abnormalities were
observed in the activation of inﬂammatory response genes (Alberts
et al., 2010) or production of chemokines and cytokines (Srivastava
et al., 2009). Furthermore, differences in the replication rates of
inﬂuenza virus within infected cells are less likely to account for this
difference in viral load because the slope of the increase in virus
replication over time was similar in both mouse lines. Also, infectionsof both mouse strains with the more virulent PR8F variant produced
similar amounts of infectious virus in infected lungs suggesting that
host factors required for viral reproduction are not generally more
supportive in DBA/2J mice.
We then looked in more detail at the structural differences between
thePR8MandPR8Fvariants. Bothvariants are closely relatedderivatives
of the PR8Mount Sinai strain but exhibited differences in the predicted
amino acid sequences in several viral proteins. The most notable
differences were found in the predicted HA sequence. The HA sequence
differed in six amino acids thatwere not located in the receptor binding
site. However, two amino acid differences surrounded the protease
cleavage site which is involved in processing of the HA0 precursor into
the two functional subunits HA1 andHA2.Modeling of the 3D-structure
of the HA sequences from the two PR8 variants suggested that the
differences in the HA of PR8F may lead to structural changes which
would allow a better interaction of the protease cleavage site with host
trypsin-like proteases. We hypothesize that this structural change may
result in a more efﬁcient processing of the PR8F HA and subsequently
would allow a faster spread of the virus.
Indeed, the low survival rate of mice infected with a genetic re-
assortant carrying the HA encoding segment of the PR8F virus in the
background of the PR8M virus (PR8M-HA-F) demonstrated that
the HA protein is the main determinant of the higher virulence of the
PR8F virus. Although clearly more virulent than the PR8M virus,
the re-assorted PR8M-HA-F virus did not result in the same mortality
rate as the PR8F virus suggesting that some of the other viral segments
which differ between PR8F and PR8M may further contribute to the
higher virulence of PR8F.
Materials and methods
Viruses
PR8M and PR8F variants are closely related to the Mount Sinai
strain of A/PR/8/34 (H1N1). They were generated by serial lung
passages in Mx1−/− mice and are referred to as “low pathogenic”
viruses (Schickli et al., 2001). Original stocks of the variant PR8M
(initially generated from plasmids kindly provided by Erich Hoff-
mann, Memphis, TN, USA) were taken from the strain collection at the
Institute of Molecular Virology, Muenster, Germany. The PR8F variant
was provided by Peter Staeheli, Department of Virology, Freiburg,
Germany. The hvPR8 (“highly virulent” PR8) variant is closely related
to the Cambridge strain of A/PR/8/34 (H1N1) (Grimm et al., 2007) and
was generated by serial passages in Mx1+/+ mice. The original stock
was also provided by Peter Staeheli. Virus stocks were propagated in
the chorio-allantoic cavity of ten days old pathogen-free embryonated
chicken eggs for 48 h at 37 °C. PR8M-HA-F virus was generated and
propagated on HEK293 and MDCK cells as described by (Hoffmann
et al., 2002). The HA segment of recombinant PR8M-HA-F virus was
sequenced after reverse transcription PCR ampliﬁcation from infected
cells to verify the presence of the desired re-assorted HA gene.
Mouse strains and infections
DBA/2J and C57BL/6J mice were purchased from Janvier, France.
Mice were maintained under speciﬁc pathogen free conditions and
according to the German animal welfare law. All experiments were
approved by an external committee according to the German
regulations on animal welfare. Animals (10–11 weeks of age) were
anesthetized by intra-peritoneal injection of Ketamine–Rompun with
a dose adjusted to the individual body weight and infected intra-
nasally with the speciﬁed dose of virus in 20 μl of sterile PBS. Weight
loss and survival of infected mice were monitored over a 14-day
period. Animals showing more than 25% of body weight loss were
euthanized and documented as dead.
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Virus titers were determined on MDCK II (Madin–Darby Canine
Kidney II) cells using the focus formation (FOCI) assay. Brieﬂy, MDCK
II cells (6×104 cells/well) were seeded in 96-well culture plates and
incubated at 37 °C in 5% CO2 for 24 h. Serial 10-fold dilutions of
extracts were prepared in DMEM containing 2.5 μg/ml NAT (N-
Acetylated Trypsin, Sigma), 0.1% BSA, 1% penicillin/streptomycin and
added to MDCK II cells. After 1 h of incubation at 37 °C in 5% CO2, the
inoculates were replaced with 100 μl of 1% Avicel overlay prepared in
DMEM containing 2.5% NAT, 0.1% BSA and the cells were incubated for
24 h. Subsequently, the cells were washed twice with PBS and ﬁxed
with 4% formalin in PBS (100 μl/well) for 10 min at room temperature.
Then, the cells were washed twice and incubated with Quencher
(100 μl/well; 0.5% Triton X-100, 20 mM Glycine in PBS) for 10 min at
room temperature. Subsequently, the cells were washed with
Washing Buffer WB (100 μl/well; 0.5% Tween20 in PBS) and blocked
with Blocking Buffer BB (50 μl/well; 0.5% Tween, 20% BSA in PBS) for
30 min at 37 °C in 5% CO2. The primary antibody (anti-inﬂuenza
Nucleocapsid NP polyclonal goat antibody, Virostat) and the second-
ary antibody (anti-goat-HRP from KPL, MA, USA) were diluted 1:1000
in Blocking Buffer (BB). 50 μl of the primary antibody was added to
each well and incubated for 1 h at room temperature. After 1 h, the
cells were washed three times with Washing Buffer WB, incubated
with 50 μl of secondary antibody for 45 min in the dark, then washed
again and incubated with 50 μl of substrate (True Blue from KPL, MA,
USA) and exposed until blue spots from infected cells appeared (about
10 min). Foci were counted and viral titers were calculated as focus
formation units (FFU) per ml of lung homogenate, lung slice
homogenate or supernatant collected from the lung slice.
Immunohistochemistry and quantiﬁcation of infected cells in lungs
Lung tissues were prepared and immersion-ﬁxed for 24 h in 4%
buffered formaldehyde solution (pH 7.4), dehydrated in a series of
graded alcohols and embedded in parafﬁn. Sections (0.5 μm)were cut
with the microtome (Microm HM340E). Subsequently, the lung
sections were stained overnight at with the primary antibody (anti-
inﬂuenza Nucleoprotein NP polyclonal goat antibody, Virostat) at 4 °C.
Then, tissue sections were incubated for 30 min with the secondary
antibody (rabbit anti-goat-biotin from KPL, MA, USA). The primary
and secondary antibodies were diluted 1:800 and 1:250 respectively.
Finally, the sections were slightly counterstained with haematoxylin
to facilitate the localization of bronchiolar and alveolar regions.
Histological sections were examined and the infected cells were
counted using an ocular with counting squares corresponding to a
25×25 μm area in combination with a 40× objective. In total, 50 areas
were investigated per lung, 10 in each lobe. For this, the 25×25 μm
square was moved over the sections and the cells in every second
interval were analyzed. For each day and each infected mouse strain,
three replicates were analyzed. All cells which showed positive NP
staining, irrespective of its intracellular location, were scored.
Flow cytometry and determination of inﬁltrating lymphocytes
Mice were sacriﬁced by CO2 inhalation, the inferior vena cava was
cut and the lung perfused by injecting 10 ml of PBS into the heart.
Subsequently, lungs were disrupted mechanically using a 100 μm cell
strainer (BD Falcon) and the piston of a syringe. The cell suspension
was centrifuged and the pellet resuspended in FACS buffer (PBS+2%
Fetal Bovine Serum+2 mM EDTA). The total number of life cells was
determined after staining with 0.4% trypan blue in a hemocytometer.
The trypan-negative cells were considered as life cells. The cell pellet
was resuspended to a concentration of 1×106 cells/100 ml. Staining
with antibodies was performed by ﬁrst blocking the Fc receptors using
a anti-CD16/32 antibody for 15 min at 4 °C. Then, the cells werecentrifuged, washed in FACS buffer and stained in 100 ml of CD45.2
(104) antibody solution for 30 min at 4 °C. Cells were centrifuged,
washed and resuspended in 100 μl FACS buffer for acquisition.
Propidium Iodide solution (PI) was added just before the measure-
ment on a LSRII FACS machine from BD. The results were analyzed
with the BD DIVA software. The total number of leukocytes in the lung
(TL) was calculated by multiplying the number of CD45.2+PI− events
(CD45.2+) with the total number of live cell counts determined by
trypan exclusion (CC), divided by the total PI− events (PI−): TL=
(CD45.2+×CC)/PI−.
Haemagglutinin protein structure prediction
Amino acid sequences of HA from PR8F and PR8Mwas aligned and
edited using ClustalW and BioEdit. Protein three-dimensional struc-
tures were obtained from RCSB PDB (Protein Data Bank; http://www.
rcsb.org). The octamer (PDB CODE: 1RU7) was dissociated into the
monomeric structure of the HA1/HA2 complex and was applied for
further investigation. SWISS MODEL server (http://www.swissmodel.
expasy.org) was used to model the structures of HA proteins. The
quality of the resulting data and the likeness of protein structure
predictions were evaluated using METAMQAP method (https://
genesilico.pl/toolkit/unimod?method=MetaMQAPII). The loops of
the HA proteins were improved with ReﬁnerLoop method (https://
genesilico.pl/toolkit/unimod?method=ReﬁnerLoop). From the 20
top-scoring models veriﬁed with METAMQAP the best scored model
was chosen.
Data analysis
Data were analyzed using GraphPad Prism version 5.00 for
Windows (GrahpPad Software, San Diego, California; http://www.
graphpad.com). Mean±SEM were calculated for percent body
weights, viral titers and number of virus-infected cells in the histology
slides. The non-parametric Mann–Whitney-U-test was used to
determine p-values for the signiﬁcance of differences between
groups. P-values of ≤0.05 were considered signiﬁcant. For compar-
isons of survival curves, a log rank test was performed using the online
tool provided by http://www.bioinf.wehi.edu.au/software/russell/
logrank/.
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